Bard C R Inc Quick Ratio (BCR) starting from the third quarter 2017 to third quarter 2016, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Quick Ratio
• Working Capital
• LT Debt to Equity
• Debt to Equity
• Leverage Ratio
• Tangible Leverage
• Interest Coverage
• Debt Coverage
• Work. Cap. Per Revenue
Bard C R Inc  (BCR)

Bard C R Inc's Quick Ratio

BCR's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


Bard C R Inc's Cash & cash equivalent grew by 15.09 % in the Q3 2017 sequentially, while Current Liabilities decreased, this led to improvement in Bard C R Inc's Quick Ratio to 0.87, Quick Ratio remained below Bard C R Inc average.

Within Medical Equipment & Supplies industry 100 other companies have achieved higher Quick Ratio than Bard C R Inc in third quarter 2017. While Quick Ratio total ranking has improved so far during the Q3 2017 to 1861, from total ranking in the second quarter 2017 at 2005.

Explain Quick Ratio?
How much Cash & cash equivalents BCR´s has?
What are BCR´s Current Liabilities?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

BCR Quick Ratio (Sep 30 2017)
Q3		 (Jun 30 2017)
Q2		 (Mar 31 2017)
Q1		 (Dec 31 2016)
Q4		 (Sep 30 2016)
Q3
Y / Y Current Liabilities Change 71.41 % 872.64 % 11.92 % -12.12 % -32.66 %
Y / Y Cash & cash equivalent Change 13.1 % 11.05 % 9.66 % 7.33 % 7.96 %
Quick Ratio MRQ 0.87 0.75 0.69 1 1.31
BCR's Total Ranking # 1861 # 2005 # 2135 # 2134 # 408
Seq. Current Liabilities Change -0.95 % -2.9 % 40.65 % 26.72 % 462.04 %
Seq. Cash & cash equivalent Change 15.09 % 5.63 % -3.32 % -3.77 % 13 %



Quick Ratio third quarter 2017 Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 101
Healthcare Sector # 550
Overall Market # 1861


Quick Ratio Statistics
High Average Low
2.78 1.58 0.69
(March 31, 2010)   (Mar 31 2017)




Financial Statements
Bard C R Inc's Current Liabilities $ 1,500 Millions Visit BCR's Balance sheet
Bard C R Inc's Cash & cash equivalent $ 1,301 Millions Visit BCR's Balance sheet
Source of BCR's Sales Visit BCR's Sales by Geography


Cumulative Bard C R Inc's Quick Ratio

BCR's Quick Ratio for the trailling 12 Months

BCR Quick Ratio

 (Sep 30 2017)
12 Months		 (Jun 30 2017)
12 Months		 (Mar 31 2017)
12 Months		 (Dec 31 2016)
12 Months		 (Sep 30 2016)
12 Months
Y / Y Current Liabilities TTM Growth 54.17 % 23.05 % -26.96 % -22.76 % -6.13 %
Y / Y Cash & cash equivalent TTM Growth 10.37 % 8.97 % 3.73 % 0.25 % -0.99 %
Quick Ratio TTM 0.81 0.88 1.17 1.2 1.13
Total Ranking TTM # 1451 # 4129 # 3924 # 3912 # 4197
Seq. Current Liabilities TTM Growth 12.35 % 36.73 % 4.7 % -4.15 % -10.32 %
Seq. Cash & cash equivalent TTM Growth 3.38 % 2.59 % 2.22 % 1.81 % 2.07 %

Quick ratio ranking by company, industry and sector >> Back to BCR Financial Strength Comparisons >> Go to Compare BCR Quick Ratio to its Competitors

On the trailing twelve months basis Due to decrease in Current Liabilities in the Q3 2017 to $1,500.00 millions, cumulative Quick Ratio decreased to 0.81 below the Bard C R Inc average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Medical Equipment & Supplies industry 83 other companies have achieved higher Quick Ratio than Bard C R Inc. While Quick Ratio overall ranking has improved so far to 1451, from total ranking during the twelve months ending second quarter 2017 at 4129.

Explain Quick Ratio?
How much Cash & cash equivalents BCR´s has?
What are BCR´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Medical Equipment & Supplies Industry # 84
Healthcare Sector # 405
Within the Market # 1451


trailing twelve months Quick Ratio Statistics
High Average Low
2.51 1.62 0.81
(March 31, 2010)   (Sep 30 2017)




Companies with similar Quick Ratio in the quarter ending Sep 30 2017, within Medical Equipment & Supplies Industry Quick RatioSep 30 2017 MRQ Cash & cash equivalentSep 30 2017 MRQ Current Liabilities
Integra Lifesciences Holdings Corp  2.29 $ 481.943  Millions$ 210.234  Millions
Antares Pharma Inc   2.14 $ 37.410  Millions$ 17.482  Millions
Electromed Inc   2.11 $ 5.787  Millions$ 2.742  Millions
Artivion Inc   2.11 $ 55.013  Millions$ 26.113  Millions
Align Technology inc   2.01 $ 679.067  Millions$ 337.948  Millions
Axogen inc   1.98 $ 22.041  Millions$ 11.138  Millions
Apyx Medical Corp  1.96 $ 9.411  Millions$ 4.806  Millions
Dariohealth Corp   1.95 $ 6.503  Millions$ 3.340  Millions
Edwards Lifesciences Corporation  1.91 $ 1,402.800  Millions$ 735.200  Millions
Lakeland Industries Inc   1.80 $ 21.493  Millions$ 11.919  Millions
Inspiremd Inc   1.75 $ 4.765  Millions$ 2.723  Millions
Retractable Technologies Inc  1.74 $ 15.866  Millions$ 9.130  Millions
Sensus Healthcare Inc   1.61 $ 9.853  Millions$ 6.122  Millions
Icu Medical Inc  1.59 $ 310.205  Millions$ 195.095  Millions
Apollo Endosurgery inc   1.44 $ 34.553  Millions$ 23.986  Millions
Endologix Inc  1.41 $ 76.988  Millions$ 54.474  Millions
Interpace Biosciences Inc   1.41 $ 11.703  Millions$ 8.302  Millions
Cas Medical Systems Inc  1.38 $ 6.289  Millions$ 4.556  Millions
Lifeward ltd   1.34 $ 12.928  Millions$ 9.617  Millions
Tearlab Corp  1.33 $ 7.713  Millions$ 5.813  Millions
Asensus Surgical Inc   1.32 $ 24.483  Millions$ 18.509  Millions
Baxter International Inc   1.32 $ 3,517.000  Millions$ 2,662.000  Millions
Medtronic Plc  1.29 $ 13,526.000  Millions$ 10,496.000  Millions
Edap Tms Sa  1.24 $ 24.049  Millions$ 19.396  Millions
Nuo Therapeutics Inc   1.17 $ 1.973  Millions$ 1.686  Millions
Fuse Medical Inc   1.13 $ 0.472  Millions$ 0.418  Millions
Nuwellis Inc   1.13 $ 2.513  Millions$ 2.227  Millions
Mimedx Group Inc   1.04 $ 36.522  Millions$ 35.159  Millions
Renovacare Inc   1.04 $ 1.150  Millions$ 1.110  Millions
Nu med Plus Inc   1.02 $ 0.409  Millions$ 0.402  Millions

Date modified: 2026-09-08T15:08:57+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.